Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16581442 | 0.80 | — | — | |
| SCHEMBL13773206 | 0.80 | — | — | |
| SCHEMBL13773200 | 0.80 | — | — | |
| SCHEMBL7760106 | 0.80 | KDM4E (0.33) | KDM4EGMNNLMNAPMP22TFPI2 | |
| SCHEMBL13773197 | 0.80 | — | — | |
| SCHEMBL4891102 | 0.80 | — | — | |
| SCHEMBL13773196 | 0.80 | — | — | |
| SCHEMBL758774 | 0.79 | LMNA (0.33) | LMNA | |
| SCHEMBL8440599 | 0.77 | — | — | |
| SCHEMBL12201001 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230056225-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-02-23 | — | — | US | disclosed |
| US-20200139433-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED METAL OXIDE FINE PARTICLE, METHOD FOR PRODUCING IMPROVED METAL OXIDE FINE PARTICLES, SURFACE-MODIFIED METAL OXIDE FINE PARTICLES, AND METAL OXIDE FINE PARTICLE DISPERSION LIQUID | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
| EP-3002304-B1 | CURABLE COMPOSITION | TOKYO OHKA KOGYO CO LTD (JP) | 2017-08-02 | — | — | EP | disclosed |
| US-20170205710-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2017-07-20 | — | — | US | disclosed |
| US-9683150-B2 | Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-06-20 | — | — | US | disclosed |
| US-9624171-B2 | Photoinitiator mixtures | BASF SE (DE) | 2017-04-18 | — | — | US | disclosed |
| EP-1770133-B1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORP (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-20120183776-A1 | CURABLE COMPOSITION, CURABLE FILM, CURABLE LAMINATE, METHOD FOR FORMING A PERMANENT PATTERN, AND PRINTED SUBSTRATE | FUJIFILM CORPORATION (JP) | 2012-07-19 | — | — | US | disclosed |
| US-7816422-B2 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2010-10-19 | — | — | US | disclosed |
| EP-1770133-A1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM Corporation (JP) | 2007-04-04 | — | — | EP | disclosed |
| US-20070071952-A1 | Curable composition, ink composition, inkjet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170205710-A1 | OXIME ESTER PHOTOINITIATORS | OR10J3, OXER1, QSOX1 | KDM4E 1549/4885GMNN 2605/4885LMNA 2575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.